Neurovascular emergencies: imaging diagnosis and neurointerventional treatment

Rahman, Wahida; Griauzde, Julius; Chaudhary, Neeraj; Pandey, Aditya S.; Gemmete, Joseph J.; Chong, Suzanne T.

doi:10.1007/s10140-016-1450-x

Cited by 11 publications

(3 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, only a limited number of patients are clinically suitable for intravenous thrombolysis therapy. As studies on cerebrovascular diseases go deeper, the minimally invasive neurointervention therapy begins to play a role in the treatment of cerebrovascular diseases (19)(20)(21). Neurointervention, a safe and highly efficient treatment, with fewer complications and less damage to the body functions, has started to be implemented in clinical practice (22).…”

Section: Discussionmentioning

confidence: 99%

Efficacy of neurointervention combined with intravenous thrombolysis in the treatment of ischemic cerebrovascular disease and its influence on neurological function and prognosis of patients

Lou

Chang

et al. 2020

Exp Ther Med

View full text Add to dashboard Cite

The present study aimed to investigate the efficacy of neurointervention combined with intravenous thrombolysis in the treatment of ischemic cerebrovascular disease (ICD) and its influence on the neurological function and prognosis of patients. A total of 119 patients with ICD admitted to Xinxiang Central Hospital (Xinxiang, China) from May 2013 to September 2015 were selected. Among them, 65 patients were enrolled in the control group and treated with intravenous thrombolysis, whereas the other 54 patients were enrolled in the observation group and were treated with intravenous thrombolysis combined with neurointervention. The National Institute of Health Stroke Scale (NIHSS) system was used to evaluate the neurological function of patients after treatment. Kaplan-Meier survival curve analysis was carried out to assess the survival of patients. The total effective rate, complications, vascular recanalization and the hospitalization time after treatment were compared between the two groups. The NIHSS scores at 1, 3 and 6 months after treatment were statistically lower in the observation group than those in the control group (P<0.05). The total effective rate and total vascular recanalization in the observation group were higher than those of the control group (P<0.05). The incidence of complications in the observation group was statistically lower than that in the control group (P<0.05). In conclusion, neurointervention combined with intravenous thrombolysis can not only effectively improve the diseased blood vessels of patients and restore the damaged nerve function, but also reduce the incidence of complications. Moreover, neurointervention combined with intravenous thrombolysis is safe and can ensure a better quality of life of patients. Patients and methods General information. A total of 119 patients with ICD admitted to Xinxiang Central Hospital (Xinxiang, China)

show abstract

Section: Discussionmentioning

confidence: 99%

Efficacy of neurointervention combined with intravenous thrombolysis in the treatment of ischemic cerebrovascular disease and its influence on neurological function and prognosis of patients

Lou

Chang

et al. 2020

Exp Ther Med

View full text Add to dashboard Cite

show abstract

“…e presence of HAVF accelerates the spread of tumors in the hepatic and throughout the body, which not only is a cause of tumor cell metastasis in the hepatic, but can also cause portal hypertension. HAPVF can cause or aggravate the symptoms of portal hypertension, such as gastrointestinal bleeding and ascites; severe life can be critical; HAVF can increase the chance of tumor cells spreading through the portal vein and hepatic vein to distant organs and can increase the false diagnosis of hepatic imaging positive rate [3]. In interventional therapy, lipiodol can cause pulmonary and systemic embolism through the shunt pathway, and hemodynamic changes due to shunt can directly affect the efficacy of transcatheter arterial chemoembolization (TACE) intervention, so understanding the imaging diagnosis and intervention of HAVF Treatment has important implications [4].…”

Section: Introductionmentioning

confidence: 99%

Imaging Diagnosis and Interventional Treatment for Hepatocellular Carcinoma Combined with Arteriovenous Fistula

Cai

Ran

Song

et al. 2021

Journal of Healthcare Engineering

View full text Add to dashboard Cite

In order to explore the imaging diagnosis methods and interventional treatment effects of hepatocellular carcinoma combined with hepatic arteriovenous fistula (HAVF), a total of 120 patients, who were diagnosed as hepatic carcinoma with arteriovenous shunting and underwent medical imaging diagnosis and interventional surgery therapy at a designated hospital by this study from December 2014 to December 2018, were chosen as study subjects. Digital subtraction angiography was performed to analyze the imaging features of hepatocellular carcinoma combined with HAVF in each patient; then, according to these imaging diagnosis results, gelatin sponge or coil was used to block the fistula; mitomycin, carboplatin powder, and lipiodol mixed emulsion was combined or separately utilized for hepatic tumor embolization, in which iodized oil embolization chemotherapy was used for patients with mild paralysis; gelatin sponge granule embolization chemotherapy was used for moderate paralysis patients at their first intervention, and, after about 1 month, if the sputum disappeared, iodized oil embolization was used again; and hepatic arterial infusion chemotherapy was used only for patients with severe paralysis. The results show that the central type of HAVF is characterized by early angiography of portal vein and large branches and tumor staining after portal vein’s angiography; the peripheral type of HAVF is characterized by portal vein branching in hepatic tumor and double rail sign accompanied by the arterial branch; 112 cases of patients completed embolization chemotherapy; 8 cases of patients only received chemotherapy perfusion; in 109 cases of patients sputum disappeared or shunt decreased at first treatment; and in 113 cases of patients iodine oil was well deposited or the tumor was stably reduced; most of the symptoms of refractory ascites, diarrhea, and upper gastrointestinal bleeding were controlled or improved, and there were no complications such as pulmonary embolism and hepatic failure. Therefore, HAVF increases the difficulty of interventional therapy, but, as long as the positive and appropriate treatment measures are taken, it can still achieve better curative effect without serious complications, which can effectively alleviate the clinical symptoms of patients and improve the quality of life of patients. The results of this study provide a reference for the further researches on imaging diagnosis and interventional treatment for hepatocellular carcinoma combined with arteriovenous fistula.

show abstract

“…Understanding these life-threatening neurovascular conditions clinically is essential for the ophthalmologist. [ 1 ] In this article, we have aimed to discuss and review the important neurovascular emergencies of the brain with regard to their clinical presentations, imaging modalities, diagnostic features, and medical and interventional management and outcome. We have searched the electronic databases, i.e., PubMed, Web of Science, and Google Scholar.…”

Section: Introductionmentioning

confidence: 99%